Navigation Links
Chronic vulvar pain a reality for more than 100,000 women in southeast Michigan
Date:9/14/2011

For more than 100,000 area women, chronic vulvar pain (pain at the opening to the vagina) is so severe it makes intercourse, and sometimes sitting for long periods of time, painful, if not impossible.

A new study from the University of Michigan, which surveyed 2,269 women in the metro Detroit area, found that more than 25 percent of women have experienced ongoing vulvar pain at some point in their lives. However, only two percent of women sought treatment for their pain.

For some, vulvar pain may be caused by activities like biking, tampon use, or intercourse, and for others it can be a persisting, spontaneous pain that can persist for up to 40 years.

Vulvodynia is characterized by a burning, irritation, or sharp pain near the opening of the vagina. The location, constancy and severity of the pain vary among women. Some women say they feel a slight discomfort, while others claim to suffer from knife-like pain. Common treatments, including topical creams, are typically directed towards alleviating symptoms and usually only provide partial pain relief.

The study, available online ahead of print in the American Journal of Obstetrics and Gynecology, found that aside from the 9.2 percent of women who reported that they were currently experiencing pain consistent with vulvodynia, an additional 17.9 percent of women reported they have experienced symptoms of vulvodynia in the past.

That factors to over 318,000 women in southeast Michigan alone.

"What this means for area women is that vulvar pain is common, it has a name, and it can be addressed with their physicians," says Barbara D. Reed, M.D., M.S.P.H, a professor of family medicine at the U-M Medical School and lead author of the study.

What researchers have found concerning is that of the two percent of women who sought treatment for their pain, five percent received a diagnosis of vulvodynia. Many women were misdiagnosed with either yeast infections or estrogen deficiency and the subsequent treatment plans they were recommended did little to alleviate their pain, suggesting these may not be causing their symptoms.

The primary goal of the study was to gain insight on the demographics of women with vulvar pain suggesting vulvodynia. Based on survey responses, researchers were able to determine the ethnicities and ages of those women with vulvar discomfort, as well as the intensity of the pain they experienced.

"With this knowledge, we better understand how common this disorder is, and who is likely to be affected. Knowing this should make it easier for medical providers to expect to see women with this problem, and will therefore make the diagnosis earlier so that treatment can proceed," Reed says.


'/>"/>
Contact: Lauren McLeod
lemcleod@med.umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Young patients with chronic illnesses find relief in acupuncture
2. Exposure to 9/11 Fumes Tied to Chronic Headaches
3. One in Two Children Has Chronic Health Issues
4. Chronic Migraines Take a Greater Toll
5. Chronic Fatigue Syndrome-Virus Link Questioned
6. Study Suggests Low-Consuming Medicare Beneficiaries With Chronic Disease Are More Costly to Program
7. Chronic Back Pain Soothed by Cognitive Behavioral Therapy
8. Virus Unlikely to Cause Chronic Fatigue Syndrome
9. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
10. National Study Reports Staggering Spending Increases Among Seniors With Chronic Conditions Through Original Medicare - Special Needs Plan Program Offers Solution For Those In Texas
11. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Seattle, WA (PRWEB) , ... February 05, 2016 ... ... consulting firm, ranked #3 in the 2015 Best in KLAS: Software & Services ... The annual Best in KLAS report independently ranks vendor performance by healthcare ...
(Date:2/5/2016)... ... , ... Stuart Bentkover, MD, FACS is thrilled to announce the ... effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts to ... has been approved by the Food and Drug Administration (FDA) as a safe and ...
(Date:2/5/2016)... ... ... In sleep, when the defenses of the day are at rest, rejected emotions ... disorders is significant self-criticism, and consequently these patients experience this disease with their feelings, ... for coping with this unease, but also leads to a reservoir of emotions that ...
(Date:2/5/2016)... Ramsey, NJ (PRWEB) , ... February 05, 2016 ... ... Optimizing Primary Care for Patients with Rare Diseases, a continuing medical education (CME) ... conference is the first of its kind—and a first for ACCORD, whose mission ...
(Date:2/5/2016)... ... 2016 , ... –This week, Atascadero water heater company First Call Plumbing ... To view the report, click here or see below. , There ... pros and cons, the type chosen is almost entirely up to personal preference. However, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... France , Germany , Italy ... ). It includes a 10-year epidemiology forecast for the total prevalent ... sex in these markets. GD epidemiology report is written and developed by ... and market-driven, providing expert analysis of disease trends in the 7MM. ... Italy , Spain , UK, and ...
(Date:2/4/2016)... 2016  The Senior Care Pharmacy Coalition (SCPC) ... Chairman Jason Chaffetz (R-UT) and Ranking ... hearing , "Developments in the Prescription Drug Market," ... questions about abusive pharmacy benefit manager (PBM) pricing ... Ranking Member Elijah Cummings (D-MD) are diligent, serious ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
Breaking Medicine Technology: